48 results
8-K
EX-10.1
DAWN
Day One Biopharmaceuticals, Inc.
30 Jul 24
Day One Announces Oversubscribed $175.0 Million Private Placement
7:04am
pandemics, including the COVID-19 pandemic and related strains, epidemic or similar health emergency, and other force majeure events in the United
S-3ASR
u15 cuwfo
14 Sep 23
Automatic shelf registration
5:28pm
424B5
a71i0ormkko
7 Jun 23
Prospectus supplement for primary offering
4:57pm
424B5
v65cofrert797x
6 Jun 23
Prospectus supplement for primary offering
4:21pm
8-K
EX-99.1
6mopjq1s7 wj2k1r
1 May 23
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
9:01am
8-K
EX-99.1
fxqzanu
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.2
j2n4d4 j8h4bivpsuf
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.2
4zry0pt
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
8-K
EX-99.1
9dfcb7i4f5ka5fhp
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
8-K
EX-99.2
v804036g40
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
EX-99.1
qfedja
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm